跳至主要内容
临床试验/NCT04739241
NCT04739241已完成4 期

Is Premixed Insulin Therapy an Alternative to Basal Bolus Therapy in Type 2 Diabetes Mellitus People Older Than 65 Years Old: A Pilot Randomised Trial

Consorci Sanitari Integral0 个研究点目标入组 60 人开始时间: 2014年1月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
主要终点
Change in HbA1c levels

研究概览

简要总结

The purpose of this study is to compare efficacy and security of premixed insulin treatment vs basal bolus insulin treatment in older patients with poorly controlled type 2 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Outpatients
  • Age ≥ 65 years old
  • Type 2 diabetes mellitus
  • HbA1c ≥9% (74 mmol/mol)
  • Previously treated with one or two doses of basal insulin and oral hypoglycaemic agents

排除标准

  • Severe insulin-resistance
  • High doses of corticosteroids
  • Chemotherapy treatment
  • High comorbidity
  • Bad compliance of the treatment
  • Frequent severe hypoglycaemia

研究组 & 干预措施

Group A (experimental arm)

Experimental

Premixed insulin therapy

干预措施: premixed insulin therapy (Drug)

Group B (active comparator)

Active Comparator

Basal bolus insulin therapy

干预措施: basal bolus insulin therapy (Drug)

结局指标

主要结局

Change in HbA1c levels

时间窗: 12 months after recruitment

Change from baseline in HbA1c levels after 12 months of therapy

次要结局

  • Change in the scores of the Diabetes Quality Of Life Questionnaire (EsDQOL) from recruitment to month 12.(12-month follow-up)
  • Incidence of hypoglycaemia as an adverse effect of the treatment(every month during the 12-month follow-up)
  • Change in the scores of the Diabetes Treatment Satisfaction Questionnaire (DTSQ) from recruitment to month 12.(12-month follow-up)
  • Incidence of dosing errors as a measure of the safety of the treatment(every month during the 12-month follow-up)

研究者

申办方类型
Other
责任方
Sponsor

相似试验